Loading clinical trials...
Loading clinical trials...
Randomized Phase III Study of Maintenance Therapy With Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
Conditions
Interventions
Paclitaxel
Carboplatin
+2 more
Locations
434
United States
Regional Medical Center
Anniston, Alabama, United States
Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
North Bay Cancer Center
Fairfield, California, United States
Todd Cancer Institute at Long Beach Memorial Medical Center
Long Beach, California, United States
Community Hospital of the Monterey Peninsula Comprehensive Cancer Center
Monterey, California, United States
Veterans Affairs Medical Center - Palo Alto
Palo Alto, California, United States
Start Date
October 25, 2010
Primary Completion Date
January 31, 2019
Completion Date
August 17, 2021
Last Updated
July 7, 2023
NCT05671510
NCT03563976
NCT06257264
NCT03340506
NCT07431827
NCT06427941
Lead Sponsor
ECOG-ACRIN Cancer Research Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions